Tudor Investment Corp ET AL Has $523,000 Stock Holdings in Huron Consulting Group Inc. (NASDAQ:HURN)

Tudor Investment Corp ET AL lessened its stake in shares of Huron Consulting Group Inc. (NASDAQ:HURN - Free Report) by 66.2% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 4,211 shares of the business services provider's stock after selling 8,251 shares during the period. Tudor Investment Corp ET AL's holdings in Huron Consulting Group were worth $523,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of the stock. TI Trust Inc. acquired a new position in shares of Huron Consulting Group in the 4th quarter valued at about $12,197,000. Franklin Resources Inc. increased its holdings in shares of Huron Consulting Group by 20.5% during the 3rd quarter. Franklin Resources Inc. now owns 395,788 shares of the business services provider's stock valued at $42,306,000 after purchasing an additional 67,239 shares in the last quarter. Norges Bank acquired a new position in shares of Huron Consulting Group in the 4th quarter valued at $7,427,000. Sunriver Management LLC grew its position in Huron Consulting Group by 10.7% during the fourth quarter. Sunriver Management LLC now owns 486,597 shares of the business services provider's stock valued at $60,465,000 after buying an additional 46,968 shares during the period. Finally, Jennison Associates LLC raised its holdings in Huron Consulting Group by 4.8% in the 4th quarter. Jennison Associates LLC now owns 601,335 shares of the business services provider's stock worth $74,722,000 after purchasing an additional 27,329 shares during the period. Institutional investors and hedge funds own 93.90% of the company's stock.

Huron Consulting Group Stock Performance

NASDAQ HURN traded up $2.74 on Monday, hitting $153.20. 265,867 shares of the company's stock were exchanged, compared to its average volume of 149,247. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.61 and a quick ratio of 1.61. The firm's 50-day moving average price is $143.19 and its two-hundred day moving average price is $131.47. Huron Consulting Group Inc. has a fifty-two week low of $84.87 and a fifty-two week high of $162.15. The firm has a market cap of $2.64 billion, a price-to-earnings ratio of 33.30 and a beta of 0.23.

Huron Consulting Group (NASDAQ:HURN - Get Free Report) last posted its quarterly earnings data on Tuesday, April 29th. The business services provider reported $1.68 earnings per share for the quarter, beating analysts' consensus estimates of $1.16 by $0.52. The business had revenue of $404.14 million during the quarter, compared to analyst estimates of $389.27 million. Huron Consulting Group had a net margin of 5.80% and a return on equity of 21.51%. The company's revenue was up 11.2% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.23 earnings per share. On average, research analysts expect that Huron Consulting Group Inc. will post 6.1 EPS for the current year.

Analyst Upgrades and Downgrades

HURN has been the subject of a number of research analyst reports. Truist Financial increased their target price on Huron Consulting Group from $165.00 to $180.00 and gave the company a "buy" rating in a report on Tuesday, March 4th. Wedbush raised their price objective on Huron Consulting Group from $150.00 to $165.00 and gave the stock an "outperform" rating in a research report on Wednesday, March 26th. Barrington Research raised their price target on Huron Consulting Group from $167.00 to $173.00 and gave the stock an "outperform" rating in a research report on Monday, May 5th. StockNews.com lowered shares of Huron Consulting Group from a "buy" rating to a "hold" rating in a report on Friday, May 2nd. Finally, Benchmark reiterated a "buy" rating and issued a $165.00 price objective on shares of Huron Consulting Group in a research note on Wednesday, March 26th. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat.com, Huron Consulting Group has an average rating of "Moderate Buy" and a consensus price target of $170.75.

Insider Transactions at Huron Consulting Group

In related news, Director John Mccartney sold 500 shares of the business's stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $151.13, for a total transaction of $75,565.00. Following the completion of the sale, the director now owns 55,688 shares of the company's stock, valued at $8,416,127.44. This represents a 0.89% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director H Eugene Lockhart sold 12,500 shares of the stock in a transaction that occurred on Wednesday, February 26th. The stock was sold at an average price of $150.00, for a total value of $1,875,000.00. Following the sale, the director now owns 12,172 shares in the company, valued at $1,825,800. The trade was a 50.66% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 76,239 shares of company stock worth $11,168,801. 2.15% of the stock is currently owned by company insiders.

Huron Consulting Group Company Profile

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children's and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.